The goal is to define on a molecular level the multifactor interactions involved in carcinogenesis. The role of specific viral genes in regulating carcinogen-enhancement of viral transformation (CET) will be studied using a highly transformable rat embryo fibroblast (CREF) cell line, well characterized type 5 adenovirus (Ad5) mutants and various molecular biological techniques. Experiments designed to determine the role of specific viral genes in regulating the CET phenotype will focus on a cold-sensitive host-range mutant of Ad5, H5hr1, which transforms CREF cells at a higher frequency than wild type Ad5 (H5wt) at 37 or 39.5 degrees C, but is defective for transformation at 32 degrees C. The H5hr1 mutant also displays a unique CET phenotype not observed in carcinogen-treated CREF cells infected with H5wt or other cold-sensitive host-range Ad5 mutants. Experiments will be designed to determine if carcinogens alter the proportion of cells in an infected population which initially contain viral DNA and ultimately become transformed. The effect of carcinogens on Ad5-gene expression in cryptically transformed CREF cells, i.e., transformed cells containing integrated Ad5 DNA but not expressing Ad5-genetic information, will also be evaluated. To define directly the role of specific regions of the H5hr1 genome in regulating the CET effect, CREF cells will be coinfected with H5hr1 and various genetically engineered Ad5 mutants and the H5hr1 genome will be reconstructed by genetic recombination techniques. To identify potentially relevant changes in cellular gene expression induced by carcinogen treatment and H5hr1 infection high resolution 2-D gel protein electrophoresis will be employed. Experiments using 2-D gel protein electrophoresis analysis will be designed to identify: (a) the temporal sequence of cellular protein changes induced by carcinogen treatment and infection with H5hr1; (b) protein alterations which are unique to specific DNA damaging and carcinogenic agents which induce a CET phenotype; and (c) by using CREF cells resistant to the CET phenotype, specific protein changes which may be crucial for induction of a CET phenotype. These studies should provide important insights into the function of specific viral genes in mediating chemical-viral carcinogenesis and should permit a further molecular definition of the multiple factors involved in the carcinogenic process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA043208-01A1
Application #
3185254
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1987-04-01
Project End
1990-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Su, Z Z; Yemul, S; Stein, C A et al. (1995) c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation. Oncogene 10:2037-49
Jiang, H; Lin, J; Su, Z Z et al. (1995) The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10:1855-64
Su, Z Z; Shen, R; O'Brian, C A et al. (1994) Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine. Oncogene 9:1123-32
Jiang, H; Lin, J; Su, Z Z et al. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-406
Leon, J A; Goldstein, N I; Fisher, P B (1994) New approaches for the development and application of monoclonal antibodies for the diagnosis and therapy of human cancer. Pharmacol Ther 61:237-78
Shen, R; Su, Z Z; Olsson, C A et al. (1994) Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface. J Natl Cancer Inst 86:91-8
Su, Z Z; Lin, J; Grunberger, D et al. (1994) Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression. Cancer Res 54:1865-70
Su, Z Z; Austin, V N; Zimmer, S G et al. (1993) Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8:1211-9
Su, Z Z; Leon, J A; Jiang, H et al. (1993) Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells. Cancer Res 53:1929-38
Su, Z Z; Shen, R; Young, C S et al. (1993) Genetic analysis of carcinogen enhancement of type 5 adenovirus transformation of cloned Fischer rat embryo fibroblast cells. Mol Carcinog 8:155-66

Showing the most recent 10 out of 27 publications